aluates Reports

$ 0.0

Automative

Global Tumor Necrosis Factor Antibody Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-19T8804

Global Tumor Necrosis Factor Antibody Market Insights Forecast to 2028

BUY CHAPTERS

Global Tumor Necrosis Factor Antibody Market Research Report 2025

Code: QYRE-Auto-19T8804

Report

July 2025

Pages:97

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Aviva Systems Biology

FineTest

Santa Cruz Biotechnology

Miltenyi Biotec

Merck

Proteintech

Hytest

Boster Biological Technology

Cusabio

ProSci

BioLegend

Bio X Cell

Bio Rad

Leinco Technologies

EXBIO

Beckman Coulter

Tumor Necrosis Factor Antibody Market

The global market for Tumor Necrosis Factor Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Anti-tumor necrosis factor (anti-TNF) antibody that was designed to block the TNF receptor in an effort to downregulate autoimmune responses.

North American market for Tumor Necrosis Factor Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tumor Necrosis Factor Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Tumor Necrosis Factor Antibody in Flow Cytometry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Tumor Necrosis Factor Antibody include Aviva Systems Biology, FineTest, Santa Cruz Biotechnology, Miltenyi Biotec, Merck, Proteintech, Hytest, Boster Biological Technology, Cusabio, ProSci, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tumor Necrosis Factor Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tumor Necrosis Factor Antibody.

The Tumor Necrosis Factor Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tumor Necrosis Factor Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tumor Necrosis Factor Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Tumor Necrosis Factor Antibody Market Report

Report Metric	Details
Report Name	Tumor Necrosis Factor Antibody Market
Segment by Type	Polyclonal Monoclonal
Segment by Application	Flow Cytometry Immunofluorescence Western Blot Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Aviva Systems Biology, FineTest, Santa Cruz Biotechnology, Miltenyi Biotec, Merck, Proteintech, Hytest, Boster Biological Technology, Cusabio, ProSci, BioLegend, Bio X Cell, Bio-Rad, Leinco Technologies, EXBIO, Beckman Coulter
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tumor Necrosis Factor Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Tumor Necrosis Factor Antibody Market report?

Ans: The main players in the Tumor Necrosis Factor Antibody Market are Aviva Systems Biology, FineTest, Santa Cruz Biotechnology, Miltenyi Biotec, Merck, Proteintech, Hytest, Boster Biological Technology, Cusabio, ProSci, BioLegend, Bio X Cell, Bio-Rad, Leinco Technologies, EXBIO, Beckman Coulter

What are the Application segmentation covered in the Tumor Necrosis Factor Antibody Market report?

Ans: The Applications covered in the Tumor Necrosis Factor Antibody Market report are Flow Cytometry, Immunofluorescence, Western Blot, Others

What are the Type segmentation covered in the Tumor Necrosis Factor Antibody Market report?

Ans: The Types covered in the Tumor Necrosis Factor Antibody Market report are Polyclonal, Monoclonal

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tumor Necrosis Factor Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polyclonal

1.2.3 Monoclonal

1.3 Market by Application

1.3.1 Global Tumor Necrosis Factor Antibody Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Flow Cytometry

1.3.3 Immunofluorescence

1.3.4 Western Blot

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tumor Necrosis Factor Antibody Market Perspective (2020-2031)

2.2 Global Tumor Necrosis Factor Antibody Growth Trends by Region

2.2.1 Global Tumor Necrosis Factor Antibody Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Tumor Necrosis Factor Antibody Historic Market Size by Region (2020-2025)

2.2.3 Tumor Necrosis Factor Antibody Forecasted Market Size by Region (2026-2031)

2.3 Tumor Necrosis Factor Antibody Market Dynamics

2.3.1 Tumor Necrosis Factor Antibody Industry Trends

2.3.2 Tumor Necrosis Factor Antibody Market Drivers

2.3.3 Tumor Necrosis Factor Antibody Market Challenges

2.3.4 Tumor Necrosis Factor Antibody Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Tumor Necrosis Factor Antibody Players by Revenue

3.1.1 Global Top Tumor Necrosis Factor Antibody Players by Revenue (2020-2025)

3.1.2 Global Tumor Necrosis Factor Antibody Revenue Market Share by Players (2020-2025)

3.2 Global Tumor Necrosis Factor Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Tumor Necrosis Factor Antibody Revenue

3.4 Global Tumor Necrosis Factor Antibody Market Concentration Ratio

3.4.1 Global Tumor Necrosis Factor Antibody Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tumor Necrosis Factor Antibody Revenue in 2024

3.5 Global Key Players of Tumor Necrosis Factor Antibody Head office and Area Served

3.6 Global Key Players of Tumor Necrosis Factor Antibody, Product and Application

3.7 Global Key Players of Tumor Necrosis Factor Antibody, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Necrosis Factor Antibody Breakdown Data by Type

4.1 Global Tumor Necrosis Factor Antibody Historic Market Size by Type (2020-2025)

4.2 Global Tumor Necrosis Factor Antibody Forecasted Market Size by Type (2026-2031)

5 Tumor Necrosis Factor Antibody Breakdown Data by Application

5.1 Global Tumor Necrosis Factor Antibody Historic Market Size by Application (2020-2025)

5.2 Global Tumor Necrosis Factor Antibody Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Tumor Necrosis Factor Antibody Market Size (2020-2031)

6.2 North America Tumor Necrosis Factor Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Tumor Necrosis Factor Antibody Market Size by Country (2020-2025)

6.4 North America Tumor Necrosis Factor Antibody Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Tumor Necrosis Factor Antibody Market Size (2020-2031)

7.2 Europe Tumor Necrosis Factor Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Tumor Necrosis Factor Antibody Market Size by Country (2020-2025)

7.4 Europe Tumor Necrosis Factor Antibody Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Tumor Necrosis Factor Antibody Market Size (2020-2031)

8.2 Asia-Pacific Tumor Necrosis Factor Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Tumor Necrosis Factor Antibody Market Size by Region (2020-2025)

8.4 Asia-Pacific Tumor Necrosis Factor Antibody Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Tumor Necrosis Factor Antibody Market Size (2020-2031)

9.2 Latin America Tumor Necrosis Factor Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Tumor Necrosis Factor Antibody Market Size by Country (2020-2025)

9.4 Latin America Tumor Necrosis Factor Antibody Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Tumor Necrosis Factor Antibody Market Size (2020-2031)

10.2 Middle East & Africa Tumor Necrosis Factor Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Tumor Necrosis Factor Antibody Market Size by Country (2020-2025)

10.4 Middle East & Africa Tumor Necrosis Factor Antibody Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Aviva Systems Biology

11.1.1 Aviva Systems Biology Company Details

11.1.2 Aviva Systems Biology Business Overview

11.1.3 Aviva Systems Biology Tumor Necrosis Factor Antibody Introduction

11.1.4 Aviva Systems Biology Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.1.5 Aviva Systems Biology Recent Development

11.2 FineTest

11.2.1 FineTest Company Details

11.2.2 FineTest Business Overview

11.2.3 FineTest Tumor Necrosis Factor Antibody Introduction

11.2.4 FineTest Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.2.5 FineTest Recent Development

11.3 Santa Cruz Biotechnology

11.3.1 Santa Cruz Biotechnology Company Details

11.3.2 Santa Cruz Biotechnology Business Overview

11.3.3 Santa Cruz Biotechnology Tumor Necrosis Factor Antibody Introduction

11.3.4 Santa Cruz Biotechnology Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.3.5 Santa Cruz Biotechnology Recent Development

11.4 Miltenyi Biotec

11.4.1 Miltenyi Biotec Company Details

11.4.2 Miltenyi Biotec Business Overview

11.4.3 Miltenyi Biotec Tumor Necrosis Factor Antibody Introduction

11.4.4 Miltenyi Biotec Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.4.5 Miltenyi Biotec Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Tumor Necrosis Factor Antibody Introduction

11.5.4 Merck Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Proteintech

11.6.1 Proteintech Company Details

11.6.2 Proteintech Business Overview

11.6.3 Proteintech Tumor Necrosis Factor Antibody Introduction

11.6.4 Proteintech Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.6.5 Proteintech Recent Development

11.7 Hytest

11.7.1 Hytest Company Details

11.7.2 Hytest Business Overview

11.7.3 Hytest Tumor Necrosis Factor Antibody Introduction

11.7.4 Hytest Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.7.5 Hytest Recent Development

11.8 Boster Biological Technology

11.8.1 Boster Biological Technology Company Details

11.8.2 Boster Biological Technology Business Overview

11.8.3 Boster Biological Technology Tumor Necrosis Factor Antibody Introduction

11.8.4 Boster Biological Technology Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.8.5 Boster Biological Technology Recent Development

11.9 Cusabio

11.9.1 Cusabio Company Details

11.9.2 Cusabio Business Overview

11.9.3 Cusabio Tumor Necrosis Factor Antibody Introduction

11.9.4 Cusabio Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.9.5 Cusabio Recent Development

11.10 ProSci

11.10.1 ProSci Company Details

11.10.2 ProSci Business Overview

11.10.3 ProSci Tumor Necrosis Factor Antibody Introduction

11.10.4 ProSci Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.10.5 ProSci Recent Development

11.11 BioLegend

11.11.1 BioLegend Company Details

11.11.2 BioLegend Business Overview

11.11.3 BioLegend Tumor Necrosis Factor Antibody Introduction

11.11.4 BioLegend Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.11.5 BioLegend Recent Development

11.12 Bio X Cell

11.12.1 Bio X Cell Company Details

11.12.2 Bio X Cell Business Overview

11.12.3 Bio X Cell Tumor Necrosis Factor Antibody Introduction

11.12.4 Bio X Cell Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.12.5 Bio X Cell Recent Development

11.13 Bio-Rad

11.13.1 Bio-Rad Company Details

11.13.2 Bio-Rad Business Overview

11.13.3 Bio-Rad Tumor Necrosis Factor Antibody Introduction

11.13.4 Bio-Rad Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.13.5 Bio-Rad Recent Development

11.14 Leinco Technologies

11.14.1 Leinco Technologies Company Details

11.14.2 Leinco Technologies Business Overview

11.14.3 Leinco Technologies Tumor Necrosis Factor Antibody Introduction

11.14.4 Leinco Technologies Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.14.5 Leinco Technologies Recent Development

11.15 EXBIO

11.15.1 EXBIO Company Details

11.15.2 EXBIO Business Overview

11.15.3 EXBIO Tumor Necrosis Factor Antibody Introduction

11.15.4 EXBIO Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.15.5 EXBIO Recent Development

11.16 Beckman Coulter

11.16.1 Beckman Coulter Company Details

11.16.2 Beckman Coulter Business Overview

11.16.3 Beckman Coulter Tumor Necrosis Factor Antibody Introduction

11.16.4 Beckman Coulter Revenue in Tumor Necrosis Factor Antibody Business (2020-2025)

11.16.5 Beckman Coulter Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Aviva Systems Biology

FineTest

Santa Cruz Biotechnology

Miltenyi Biotec

Merck

Proteintech

Hytest

Boster Biological Technology

Cusabio

ProSci

BioLegend

Bio X Cell

Bio Rad

Leinco Technologies

EXBIO

Beckman Coulter

List of Tables

Table 1. Global Tumor Necrosis Factor Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polyclonal

Table 3. Key Players of Monoclonal

Table 4. Global Tumor Necrosis Factor Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Tumor Necrosis Factor Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Tumor Necrosis Factor Antibody Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Tumor Necrosis Factor Antibody Market Share by Region (2020-2025)

Table 8. Global Tumor Necrosis Factor Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Tumor Necrosis Factor Antibody Market Share by Region (2026-2031)

Table 10. Tumor Necrosis Factor Antibody Market Trends

Table 11. Tumor Necrosis Factor Antibody Market Drivers

Table 12. Tumor Necrosis Factor Antibody Market Challenges

Table 13. Tumor Necrosis Factor Antibody Market Restraints

Table 14. Global Tumor Necrosis Factor Antibody Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Tumor Necrosis Factor Antibody Market Share by Players (2020-2025)

Table 16. Global Top Tumor Necrosis Factor Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Antibody as of 2024)

Table 17. Ranking of Global Top Tumor Necrosis Factor Antibody Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Tumor Necrosis Factor Antibody Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Tumor Necrosis Factor Antibody, Headquarters and Area Served

Table 20. Global Key Players of Tumor Necrosis Factor Antibody, Product and Application

Table 21. Global Key Players of Tumor Necrosis Factor Antibody, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Tumor Necrosis Factor Antibody Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Tumor Necrosis Factor Antibody Revenue Market Share by Type (2020-2025)

Table 25. Global Tumor Necrosis Factor Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Tumor Necrosis Factor Antibody Revenue Market Share by Type (2026-2031)

Table 27. Global Tumor Necrosis Factor Antibody Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Tumor Necrosis Factor Antibody Revenue Market Share by Application (2020-2025)

Table 29. Global Tumor Necrosis Factor Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Tumor Necrosis Factor Antibody Revenue Market Share by Application (2026-2031)

Table 31. North America Tumor Necrosis Factor Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Tumor Necrosis Factor Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Tumor Necrosis Factor Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Tumor Necrosis Factor Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Tumor Necrosis Factor Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Tumor Necrosis Factor Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Tumor Necrosis Factor Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Tumor Necrosis Factor Antibody Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Tumor Necrosis Factor Antibody Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Tumor Necrosis Factor Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Tumor Necrosis Factor Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Tumor Necrosis Factor Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Tumor Necrosis Factor Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Tumor Necrosis Factor Antibody Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Tumor Necrosis Factor Antibody Market Size by Country (2026-2031) & (US$ Million)

Table 46. Aviva Systems Biology Company Details

Table 47. Aviva Systems Biology Business Overview

Table 48. Aviva Systems Biology Tumor Necrosis Factor Antibody Product

Table 49. Aviva Systems Biology Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 50. Aviva Systems Biology Recent Development

Table 51. FineTest Company Details

Table 52. FineTest Business Overview

Table 53. FineTest Tumor Necrosis Factor Antibody Product

Table 54. FineTest Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 55. FineTest Recent Development

Table 56. Santa Cruz Biotechnology Company Details

Table 57. Santa Cruz Biotechnology Business Overview

Table 58. Santa Cruz Biotechnology Tumor Necrosis Factor Antibody Product

Table 59. Santa Cruz Biotechnology Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 60. Santa Cruz Biotechnology Recent Development

Table 61. Miltenyi Biotec Company Details

Table 62. Miltenyi Biotec Business Overview

Table 63. Miltenyi Biotec Tumor Necrosis Factor Antibody Product

Table 64. Miltenyi Biotec Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 65. Miltenyi Biotec Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Tumor Necrosis Factor Antibody Product

Table 69. Merck Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Proteintech Company Details

Table 72. Proteintech Business Overview

Table 73. Proteintech Tumor Necrosis Factor Antibody Product

Table 74. Proteintech Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 75. Proteintech Recent Development

Table 76. Hytest Company Details

Table 77. Hytest Business Overview

Table 78. Hytest Tumor Necrosis Factor Antibody Product

Table 79. Hytest Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 80. Hytest Recent Development

Table 81. Boster Biological Technology Company Details

Table 82. Boster Biological Technology Business Overview

Table 83. Boster Biological Technology Tumor Necrosis Factor Antibody Product

Table 84. Boster Biological Technology Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 85. Boster Biological Technology Recent Development

Table 86. Cusabio Company Details

Table 87. Cusabio Business Overview

Table 88. Cusabio Tumor Necrosis Factor Antibody Product

Table 89. Cusabio Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 90. Cusabio Recent Development

Table 91. ProSci Company Details

Table 92. ProSci Business Overview

Table 93. ProSci Tumor Necrosis Factor Antibody Product

Table 94. ProSci Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 95. ProSci Recent Development

Table 96. BioLegend Company Details

Table 97. BioLegend Business Overview

Table 98. BioLegend Tumor Necrosis Factor Antibody Product

Table 99. BioLegend Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 100. BioLegend Recent Development

Table 101. Bio X Cell Company Details

Table 102. Bio X Cell Business Overview

Table 103. Bio X Cell Tumor Necrosis Factor Antibody Product

Table 104. Bio X Cell Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 105. Bio X Cell Recent Development

Table 106. Bio-Rad Company Details

Table 107. Bio-Rad Business Overview

Table 108. Bio-Rad Tumor Necrosis Factor Antibody Product

Table 109. Bio-Rad Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 110. Bio-Rad Recent Development

Table 111. Leinco Technologies Company Details

Table 112. Leinco Technologies Business Overview

Table 113. Leinco Technologies Tumor Necrosis Factor Antibody Product

Table 114. Leinco Technologies Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 115. Leinco Technologies Recent Development

Table 116. EXBIO Company Details

Table 117. EXBIO Business Overview

Table 118. EXBIO Tumor Necrosis Factor Antibody Product

Table 119. EXBIO Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 120. EXBIO Recent Development

Table 121. Beckman Coulter Company Details

Table 122. Beckman Coulter Business Overview

Table 123. Beckman Coulter Tumor Necrosis Factor Antibody Product

Table 124. Beckman Coulter Revenue in Tumor Necrosis Factor Antibody Business (2020-2025) & (US$ Million)

Table 125. Beckman Coulter Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Tumor Necrosis Factor Antibody Picture

Figure 2. Global Tumor Necrosis Factor Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Tumor Necrosis Factor Antibody Market Share by Type: 2024 VS 2031

Figure 4. Polyclonal Features

Figure 5. Monoclonal Features

Figure 6. Global Tumor Necrosis Factor Antibody Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Tumor Necrosis Factor Antibody Market Share by Application: 2024 VS 2031

Figure 8. Flow Cytometry Case Studies

Figure 9. Immunofluorescence Case Studies

Figure 10. Western Blot Case Studies

Figure 11. Others Case Studies

Figure 12. Tumor Necrosis Factor Antibody Report Years Considered

Figure 13. Global Tumor Necrosis Factor Antibody Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Tumor Necrosis Factor Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Tumor Necrosis Factor Antibody Market Share by Region: 2024 VS 2031

Figure 16. Global Tumor Necrosis Factor Antibody Market Share by Players in 2024

Figure 17. Global Top Tumor Necrosis Factor Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Antibody as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Tumor Necrosis Factor Antibody Revenue in 2024

Figure 19. North America Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Tumor Necrosis Factor Antibody Market Share by Country (2020-2031)

Figure 21. United States Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Tumor Necrosis Factor Antibody Market Share by Country (2020-2031)

Figure 25. Germany Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Tumor Necrosis Factor Antibody Market Share by Region (2020-2031)

Figure 33. China Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Tumor Necrosis Factor Antibody Market Share by Country (2020-2031)

Figure 41. Mexico Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Tumor Necrosis Factor Antibody Market Share by Country (2020-2031)

Figure 45. Turkey Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Tumor Necrosis Factor Antibody Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Aviva Systems Biology Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 49. FineTest Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 50. Santa Cruz Biotechnology Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 51. Miltenyi Biotec Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 53. Proteintech Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 54. Hytest Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 55. Boster Biological Technology Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 56. Cusabio Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 57. ProSci Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 58. BioLegend Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 59. Bio X Cell Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 60. Bio-Rad Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 61. Leinco Technologies Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 62. EXBIO Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 63. Beckman Coulter Revenue Growth Rate in Tumor Necrosis Factor Antibody Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030

Global Tumor Necrosis Factor TNF Antagonists Market Research Report 2024

Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Tumor Necrosis Factor TNF Inhibitor Drugs Market Insights Forecast to 2030

Global Tumor Necrosis Factor Alpha Inhibitors Market Research Report 2024

Global Tumor Necrosis Factor Inhibitors Market Research Report 2024

Adalimumab Humira and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TNF Inhibitors for the Treatment of Rheumatoid Arthritis Market Research Report 2024

Global Recombinant Human Tumor Necrosis Factor α ReceptorⅡ IgG Fc Fusion Protein for Injection Market Research Report 2024

Global TNFSF9 Antibody Market Research Report 2024

Tumor Necrosis Factor ELISA Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global TNF Blockers Market Research Report 2024

Global CD30 TNFRSF8 Antibody Market Research Report 2024

Global TNF Alpha Inhibitor Market Research Report 2024

Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market Research Report 2025

Global Tumor Necrosis Factor Alpha TNF α ELISA Kit Market Research Report 2024

Global Etanercept Solution for Injection Market Research Report 2024

Global Tumor Necrosis Factor Inhibitors Drug Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28I6901

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22R9736

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29A2598

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions